Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.

about

A New Venue of TNF Targeting.TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors.TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders.

P2860

Q55001725-B9960890-9608-4C90-A0E6-693EC2CF09E7 Q55074144-3A06AF80-F5D5-4C69-8657-B30CBD953B3D Q55434021-AF28DA29-EE25-4F7A-AABA-989763763025

P2860

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.

Item

http://www.wikidata.org/entity/Q48319209

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@en

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@nl

type

Item

label

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@en

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@nl

prefLabel

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@en

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer.

@nl

P1476

Blockade of TNFR2 signaling en ...... a mouse model of colon cancer

@en

P2093

Anna L Trivett

http://www.w3.org/2001/XMLSchema#string

De Yang

http://www.w3.org/2001/XMLSchema#string

Dennis M Klinman

http://www.w3.org/2001/XMLSchema#string

Hidekazu Shirota

http://www.w3.org/2001/XMLSchema#string

Jiang He

http://www.w3.org/2001/XMLSchema#string

Joost J Oppenheim

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Yingjie Nie

http://www.w3.org/2001/XMLSchema#string

P2860

The role of regulatory T cells in cancer immunology

Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma

PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia

Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X.

Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.

Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.

Immunotherapeutic uses of CpG oligodeoxynucleotides.

P31

scholarly article

P356

10.1126/SCISIGNAL.AAN0790

http://www.w3.org/2001/XMLSchema#string

P433

511

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29295954

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.

about

P2860

P2860

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921